The invention relates to combinations of 4-[(S)-2-Azetidin-1-yl-1-(4-chloro-3- trifluoromethyl-phenyl)-ethylamino]-quinazoline-8-carboxylic acid amide and/or its physiologically acceptable salts and solvates, and an inhibitor of Her2, and the use of such combinations for the treatment of cancer.Linvention concerne des associations dun amide de lacide 4-[(S)-2-azétidine-1-yl-1-(4-chloro-3-trifluorométhyl-phényl)-éthylamino]-quinazoline-8-carboxylique et/ou ses sels et solvates physiologiquement acceptables et dun inhibiteur de Her2. Linvention concerne également lutilisation de ces associations pour le traitement du cancer.
